Weaker expectations for the oil & gas business
07/11/19 -"This led to an impairment (92% for goodwill) on the former Rhodia and Chemlogics activities (Novecare – Advance Formulations), which damaged the Q3 figures and came fully out of the blue. In ..."
Pages
60
Language
English
Published on
07/11/19
You may also be interested by these reports :
07/10/26
2026E: The reduction in our EPS estimate mainly reflects a more cautious view on potash prices in H2 2026, compounded by likely higher freight costs. ...
07/10/26
The FT reports that the European Commission’s pesticide omnibus, which partly mirrors industry lobbying, intends to make approvals unlimited, ease ...
02/10/26
Lower earnings expectations but a positive CMD impression
23/09/26
Johnson Matthey (UK, Reduce) has spent the past few years doing what many industrial conglomerates eventually do: shedding parts of itself until only ...